The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast

Medical Mycology

Volumn 51, Issue 5, 2013, Pages 461-472

  Mesa Arango, Ana Cecilia ^a,b   Forastiero, Agustina ^a   Bernal Martínez, Leticia ^a   Cuenca Estrella, Manuel ^a   Mellado, Emilia ^a   Zaragoza, Oscar ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Antifungal drugs; Candida tropicalis; Galleria mellonella; Phagocytosis; Virulence

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; VORICONAZOLE;

ARTICLE; BLOOD CELL; CANDIDA TROPICALIS; CANDIDIASIS; CELL AGGREGATION; CELL DENSITY; CELL PHAGOCYTOSIS; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; FUNGAL CELL; FUNGAL STRAIN; FUNGAL VIRULENCE; GALLERIA MELLONELLA; HEMOLYMPH; HOST PATHOGEN INTERACTION; INOCULATION; LARVA; NONHUMAN; STRAIN DIFFERENCE; SURVIVAL TIME; TEMPERATURE; YEAST CELL;

CANDIDA TROPICALIS; FILOBASIDIELLA NEOFORMANS; GALLERIA MELLONELLA; HEXAPODA; LEPIDOPTERA; MAMMALIA;

EID: 84879926068     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.737031     Document Type: Article

References (41)

1. Almirante B, Rodriguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005; 43: 1829-1835.
2. Bassetti M, Taramasso L, Nicco E, et al. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 2011; 6: e24198.
3. Silva S, Negri M, Henriques M, et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012; 36: 288-305.
4. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. Antimicrob Agents Chemother 2011; 55: 561-566.
5. Colombo AL, Nucci M, Park BJ, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006; 44: 2816-2823.
6. Peman J, Canton E, Quindos G, et al. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 2012; 67: 1181-1187.
7. Negri M, Silva S, Henriques M, Oliveira R. Insights into Candida tropicalis nosocomial infections and virulence factors. Eur J Clin Microbiol Infect Dis 2012; 31: 1399-1412.
8. Muñoz P, Giannella M, Fanciulli C, et al. Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect 2011; 17: 1538-1545.
9. Cuenca-Estrella M, Gomez-Lopez A, Cuesta I, et al. Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida spp. according to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 2011; 55: 1794-1797.
10. Tortorano AM, Prigitano A, Dho G, Grancini A, Passera M. Antifungal susceptibility profiles of Candida isolates from a prospective survey of invasive fungal infections in Italian intensive care units. J Med Microbiol 2012; 61: 389-393.
11. Schmalreck AF, Willinger B, Haase G, et al. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Mycoses 2012; 55: e124-137.
12. Okawa Y, Miyauchi M, Kobayashi H. Comparison of pathogenicity of various Candida tropicalis strains. Biol Pharm Bull 2008; 31: 1507-1510.
13. Marine M, Pastor FJ, Guarro J. Efficacy of posaconazole in a murine disseminated infection by Candida tropicalis. Antimicrob Agents Chemother 2010; 54: 530-532.
14. Mylonakis E, Aballay A. Worms and fl ies as genetically tractable animal models to study host-pathogen interactions. Infect Immun 2005; 73: 3833-3841.
15. Chrisman CJ, Albuquerque P, Guimaraes AJ, Nieves E, Casadevall A. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. PLoS Pathog 2011; 7: e1002047.
16. Muhammed M, Fuchs BB, Wu MP, et al. The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system. Med Mycol 2012; 50: 488-496.
17. Cotter G, Doyle S, Kavanagh K. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol 2000; 27: 163-169.
18. Mylonakis E, Moreno R, El Khoury JB, et al. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 2005; 73: 3842-3850.
19. Garcia-Rodas R, Casadevall A, Rodriguez-Tudela JL, Cuenca-Estrella M, Zaragoza O. Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS One 2011; 6: e24485.
20. Brennan M, Thomas DY, Whiteway M, Kavanagh K. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol 2002; 34: 153-157.
21. Cheema MS, Christians JK. Virulence in an insect model differs between mating types in Aspergillus fumigatus. Med Mycol 2011; 49: 202-207.
22. Kelly J, Kavanagh K. Caspofungin primes the immune response of the larvae of Galleria mellonella and induces a non-specific antimicrobial response. J Med Microbiol 2011; 60: 189-196.
23. Lionakis MS. D rosophila and G alleria insect model hosts: new tools for the study of fungal virulence, pharmacology and immunology. Virulence 2011; 2: 521-527.
24. Cowen LE, Singh SD, Kohler JR, et al. H arnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci USA 2009; 106: 2818-2823.
25. Fuchs BB, Mylonakis E. Using non-mammalian hosts to study fungal virulence and host defense. Curr Opin Microbiol 2006; 9: 346-351.
26. Kavanagh K, Reeves EP. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol Rev 2004; 28: 101-112.
27. Vilmos P, Kurucz E. Insect immunity: evolutionary roots of the mammalian innate immune system. Immunol Lett 1998; 62: 59-66.
28. Ratcliffe NA. Invertebrate immunity - a primer for the non-specialist. Immunol Lett 1985; 10: 253-270.
29. Coleman JJ, Muhammed M, Kasperkovitz PV, Vyas JM, Mylonakis E. Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host. Fungal Biol 2011; 115: 1279- 1289.
30. Peleg AY, Jara S, Monga D, et al. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 2009; 53: 2605-2609.
31. Bergin D, Brennan M, Kavanagh K. Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of Galleria mellonella. Microbes Infect 2003; 5: 1389-1395.
32. Fuchs BB, O ' Brien E, Khoury JB, Mylonakis E. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 2010; 1: 475-482.
33. Tojo S, Naganuma F, Arakawa K, Yokoo S. Involvement of both granular cells and plasmatocytes in phagocytic reactions in the greater wax moth, Galleria mellonella. J Insect Physiol 2000; 46: 1129-1135.
34. Kurtzman CP, Fell JW. The Yeasts: A Taxonomical Study. Amsterdam: Elsevier, 1997.
35. Glavis-Bloom J, Muhammed M, Mylonakis E. Of model hosts and man: using Caenorhabditis elegans, Drosophila melanogaster and Galleria mellonella as model hosts for infectious disease research. Adv Exp Med Biol 2012; 710: 11-17.
36. Whiteway M, Oberholzer U. Candida morphogenesis and hostpathogen interactions. Curr Opin Microbiol 2004; 7: 350-357.
37. Romani L, Bistoni F, Puccetti P. Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. Curr Opin Microbiol 2003; 6: 338- 343.
38. Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2006; 2: e129.
39. Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 2011; 10: 112-122.
40. Moyes DL, Runglall M, Murciano C, et al. A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe 2010; 8: 225-235.
41. Mowlds P, Kavanagh K. Effect of pre-incubation temperature on susceptibility of Galleria mellonella larvae to infection by Candida albicans. Mycopathologia 2008; 165: 5-12.